SEC Form 4 · accession 0001235802-18-000165
Wright Medical Group N.V. · WMGI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth H Weatherman
Director
Period of report
Nov 19, 2018
Accepted (ET)
Nov 20, 2018 · 4:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492658
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareF1,F2 | Nov 19, 2018 | M | 7,800 | $25.20 | A | 26,251 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF1 | Nov 19, 2018 | M | 5,509 | $20.62 | A | 31,760 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF3,F1 | Nov 19, 2018 | S | 13,309 | $28.5717 | D | 18,451 | D | |
| Ordinary Shares, par value EUR 0.03 per shareF4,F1 | Nov 19, 2018 | S | 2,640 | $28.9165 | D | 15,811 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $25.20 | Nov 19, 2018 | M | 7,800 | D | — | May 12, 2021 | Ordinary Shares | 7,800 | 0 | D |
| Stock Option (right to buy)F5 | $20.62 | Nov 19, 2018 | M | 5,509 | D | — | Oct 13, 2025 | Ordinary Shares | 5,509 | 0 | D |
Explanation of responses
- F1Includes 6,408 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan.
- F2Total holdings were increased by one ordinary share due to a rounding error in the Form 4 report that was filed with the SEC on July 26, 2018.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.42 to $28.76, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.52 to $29.16, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- F5This option has fully vested.